A Prospective, Multi-center, Open-labeled, Randomized Clinical Trial of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant Recipients to Compare QD Early Conversion and BID Tacrolimus Formulation.
Latest Information Update: 06 Jun 2020
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 04 Jun 2020 Planned End Date changed from 30 Sep 2019 to 30 Sep 2025.
- 04 Jun 2020 Planned primary completion date changed from 31 Aug 2019 to 31 Aug 2023.
- 30 Jul 2018 Status changed from not yet recruiting to recruiting.